Vijoice Back On The Table As Novartis Set To Discuss New Alpelisib Filing With EMA

The EMA has scheduled oral explanations for three medicines (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from EU CHMP

More from Product Reviews